CCS
LEGN icon

Concentric Capital Strategies’s Legend Biotech LEGN Stock Holding History

Concentric Capital Strategies’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,188
Closed -$483K – 278
2023
Q3 		$483K Buy
+7,188
New +$499K 0.05% 164

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Concentric Capital Strategies's LEGN Position: Q4 2023 in Review

Concentric Capital Strategies sold out of Legend Biotech (LEGN) in Q4 2023, closing a stake of 7,188 shares — an estimated $483K sold.

Concentric Capital Strategies first reported a position in LEGN in Q3 2023 and held it in 1 quarter. The position peaked at $483K in Q3 2023. 206 funds tracked by Wall St. Rank hold LEGN as of Q4 2023.

  • Concentric Capital Strategies reported no remaining Legend Biotech position as of Q4 2023 after selling out during the quarter.
  • Concentric Capital Strategies sold 7,188 Legend Biotech shares in Q4 2023, an estimated $483K.
  • Concentric Capital Strategies first reported a position in Legend Biotech in Q3 2023 and held it in 1 quarter.
  • Concentric Capital Strategies's Legend Biotech position peaked at $483K in Q3 2023.
  • 206 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2023.

Based on Concentric Capital Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.